Author(s):
Debarupa Dutta, Prithviraj Chakraborty
Email(s):
debarupa29@yahoo.com
DOI:
Not Available
Address:
Debarupa Dutta*1, Prithviraj Chakraborty2
1Dept. of Pharma. Chemistry, Himalayan Pharmacy Institute, Majhitar, Rangpo, East Sikkim, PIN-737136
2S.D. College of Pharmacy, Barnala, Punjab, PIN 148101
*Corresponding Author
Published In:
Volume - 1,
Issue - 2,
Year - 2009
ABSTRACT:
Diseases are born with man and drugs came into existence since a very early time to remove pain of diseases and to cure them. But at times the drug is not developed into a usable medicine because the costs incurred will not be recovered by the developer. As a result the free market economy is liable to leave some rare diseases as untreated. Such a disease is called orphan disease, the drug as orphan drug, and the sufferer as orphan patient. The objective of this review is to highlight the historical background, classification, lists of orphan drugs along with the recent pharmaceutical development and clinical use.
Cite this article:
Debarupa Dutta, Prithviraj Chakraborty. ORPHAN DRUGS - ITS PROS AND CONS. Research J. Pharma. Dosage Forms and Tech. 2009; 1(2): 59-66 .
Cite(Electronic):
Debarupa Dutta, Prithviraj Chakraborty. ORPHAN DRUGS - ITS PROS AND CONS. Research J. Pharma. Dosage Forms and Tech. 2009; 1(2): 59-66 . Available on: https://rjpdft.com/AbstractView.aspx?PID=2009-1-2-1